Meritage Portfolio Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$3.45M Sell
35,931
-438
-1% -$42.5K 0.23% 129
2025
Q3
$3.46M Sell
36,369
-552
-1% -$50.7K 0.23% 127
2025
Q2
$3.22M Sell
36,921
-2,676
-7% -$227K 0.2% 135
2025
Q1
$3.56M Sell
39,597
-351
-0.9% -$31.4K 0.24% 120
2024
Q4
$3.19M Buy
+39,948
New +$3.46M 0.2% 130
2023
Q4
Sell
-37,936
Closed -$2.97M 345
2023
Q3
$2.97M Sell
37,936
-520
-1% -$43.5K 0.22% 136
2023
Q2
$3.39M Buy
38,456
+1,548
+4% +$133K 0.24% 136
2023
Q1
$2.98M Buy
36,908
+1,278
+4% +$104K 0.22% 141
2022
Q4
$2.77M Buy
35,630
+14,007
+65% +$1.14M 0.22% 148
2022
Q3
$1.75M Buy
+21,623
New +$1.94M 0.14% 175
2015
Q3
Sell
-3,235
Closed -$240K 207
2015
Q2
$240K Buy
3,235
+535
+20% +$40.9K 0.03% 201
2015
Q1
$210K Buy
+2,700
New +$205K 0.02% 204
2014
Q3
Sell
-59,045
Closed -$3.77M 208
2014
Q2
$3.77M Buy
59,045
+940
+2% +$57.1K 0.41% 148
2014
Q1
$3.58M Buy
58,105
+775
+1% +$45.1K 0.43% 135
2013
Q4
$3.29M Sell
57,330
-2,670
-4% -$151K 0.41% 130
2013
Q3
$3.19M Buy
60,000
+1,870
+3% +$101K 0.41% 126
2013
Q2
$2.99M Buy
+58,130
New +$2.87M 0.43% 120

Other funds holding MDT

Meritage Portfolio Management's MDT Position: Q4 2025 in Review

Meritage Portfolio Management reduced its Medtronic (MDT) stake by 1.2% in Q4 2025, selling an estimated $42.5K and leaving 35,931 shares worth $3.45M. The position accounts for 0.23% of the portfolio, ranked #129.

Meritage Portfolio Management first reported a position in MDT in Q2 2013 and has held it in 17 quarters since. The position peaked at $3.77M in Q2 2014. 2,314 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • Meritage Portfolio Management held 35,931 shares of Medtronic worth $3.45M as of Q4 2025.
  • Meritage Portfolio Management sold 438 Medtronic shares in Q4 2025, an estimated $42.5K.
  • Medtronic made up 0.23% of Meritage Portfolio Management's portfolio in Q4 2025, its #129 holding.
  • Meritage Portfolio Management first reported a position in Medtronic in Q2 2013 and has held it in 17 quarters since.
  • Meritage Portfolio Management's Medtronic position peaked at $3.77M in Q2 2014.
  • 2,314 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Meritage Portfolio Management's 13F filing for Q4 2025, filed 27 Jan 2026.